Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC enrichment system from blood sample; and cell isolators, IF stainers, cell image analyzers, time laps analyzers, isolation kits, and culture kits. The company was founded in 2010 and is headquartered in Seoul, South Korea.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

Bio-Rad Innovations SAS engages in the development and production of chemicals used in biochemical, pharmaceutical and other life science research applications. The company is headquartered in Paris, France.

Zhejiang Yuehai Feed Co., Ltd., established on 2007-03-30, Business scope includes general items:fertilizer sales;Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:feed production;Veterinary drug business;aquaculture(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shanghai Beijia Biochemical Reagent Co., Ltd., established on 2002-01-11, The scope of business includes Class II6840Production of in vitro diagnostic reagents,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Lanzhou Rongye Biotechnology Co., Ltd., established on 2004-03-19, Business scope includes fetal bovine serum,Development of newborn bovine serum and other animal serum,to develop,Sales;Production of animal serum proteins and related raw materials developed using animal serum,to develop,Sales.Development of cell culture-related media and reagent consumables,development and sales(Does not contain medical treatment and drugs);Related Biotechnology Consulting;Biological scientific research instruments and consumables(Free of Hazardous Chemicals)Wholesale and retail;fetal cow,Acquisition of newborn cattle and other livestock products and animal appendages(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Zhongtuo Medical Laboratory Co., Ltd., established on 2018-06-27, Business scope includes general items:Crop pest control services;Forestry Pest Control Services;Termite Control Services;Vector biological control services;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:medical service;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Zhongtuo Biological Co., Ltd., established on 2013-12-04, The scope of business includes the production of Class I medical devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;daily mask(non-medical)Production;daily mask(non-medical)Sales;Wholesale of protective equipment for medical staff;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export.(Licensed or licensed to operate,Operating with a valid license or qualification certificate;Except for projects prohibited by laws and regulations and decisions of the State Council or requiring pre-approval:Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhongke Mayo (Shandong) Medical Laboratory Co., Ltd., established on 2018-12-12, Business scope includes general items:Remote Health Management Services;Big data service;software development;Network and Information Security Software Development;Information system operation and maintenance services;Information Technology Consulting Services;Network technology service;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:medical service;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Guangdong Yuejia Feed Co., Ltd., established on 2003-09-24, Business scope includes licensed projects:feed production;Veterinary drug business;aquaculture.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;fertilizer sales;Fishing Machinery Sales;Feed Raw Material Sales;Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shaanxi Suyuan Agricultural Development Co., Ltd., established on 2013-03-08, The scope of business includes technical research and development and technical services of agricultural technology;to plant,farming;to plant,Sales of farmed products;Biopharmaceuticals,Veterinary Drugs,Diagnostic reagents,Veterinary Drug Additives,Feed additives,disinfectant,laboratory consumables,Agricultural and sideline products,Feed development and sales;Farming equipment and equipment,electronic product,pet supplies,R & D and sales of labor insurance products;Research and development and promotion of animal husbandry technology;to plant,Breeding technology research and development and technical services;Animal Husbandry Professional and Auxiliary Activities;Inspection and Quarantine Services;Testing service;Quality Inspection Technical Services;Business Consulting(finance,securities,futures,Except for special control such as fund investment consulting);Enterprise Management Information Consulting;Safety Program Evaluation,Evaluation of Technical Advisory Services;Information processing and storage support services;Technical service of computer network technology;General cargo road transport(except dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company's lead product, DX-88, has been approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug Administration (FDA) for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. The Company commercializes KALBITOR on its own in the United States. In addition to its approved commercial use for HAE in the United States, the Company is also developing DX-88 through collaborations in other indications. These include use of DX-88 for the reduction of blood loss during surgery in collaboration with Cubist Pharmaceuticals (Cubist), and for treatment of retinal diseases in collaboration with Fovea Pharmaceuticals (Fovea), which was acquired by sanofi-aventis during the year ended December 31, 2009.

American Cyanamid Company was a U.S.-based diversified company with businesses in several fields. The company was a manufacturer of agricultural chemicals, cosmetics, perfumes, building products, plastics and pharmaceuticals. The company was listed as a top 100 manufacturing company by Fortune magazine in the 1970s. Cyanamid was founded in 1907 and employed over 100,000 people around the world by 2000. The company maintained a monopoly over tetracycline, an antibiotic used against bacterial infections. A theft of the organism led to the loss of the monopoly as rival companies were able to produce generic versions of the formula, leading to huge losses to the company. The company sold most of its businesses in the early 2000s and is now operated under the name Cytec.  

Xituo Biotechnology Co., Ltd., established on 2017-08-24, Business scope includes biological products,Technical research and development of pharmaceutical products,technical consulting,technology transfer,Technical service and sales;R&D and sales of agricultural biotechnology products.